Synthesis of novel, peptidic kinase inhibitors with cytostatic/cytotoxic activity

Bioorg Med Chem. 2014 Mar 1;22(5):1773-81. doi: 10.1016/j.bmc.2014.01.005. Epub 2014 Jan 10.

Abstract

The utility of a novel, chemoenzymatic procedure for the stereocontrolled synthesis of small peptides is presented in the preparation and structure optimisation of dipeptides with cytostatic/cytotoxic activity. The method uses Passerini multicomponent reaction for the preparation of racemic scaffold which is then enantioselectively hydrolysed by hydrolytic enzymes. Products of these transformations are further functionalised towards title compounds. Both activity and selectivity towards tumor cells is optimised. Final compound is shown to be an inhibitor of the protein kinase signaling pathway.

Keywords: Biotransformations; Cytostatic/cytotoxic effect; Kinase inhibitors; Peptidomimetics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytostatic Agents / pharmacology*
  • Dipeptides / chemical synthesis*
  • Humans
  • Molecular Structure
  • Peptidomimetics / chemical synthesis*
  • Protein Kinase Inhibitors / pharmacology*

Substances

  • Cytostatic Agents
  • Dipeptides
  • Peptidomimetics
  • Protein Kinase Inhibitors